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Nanobodies are emerging tools in a variety of fields such as structural
biology, cell imaging, and drug discovery. Here we pioneer the use
of their spin-labeled variants as reporters of conformational dy-
namics of membrane proteins using DEER spectroscopy. At the
example of the bacterial ABC transporter TM287/288, we show that
two gadolinium-labeled nanobodies allow us to quantify, via analysis
of the modulation depth of DEER traces, the fraction of transporters
adopting the outward-facing state under different experimental
conditions. Additionally, we quantitatively follow the interconver-
sion from the outward- to the inward-facing state in the conforma-
tional ensemble under ATP turnover conditions. We finally show that
the specificity of the nanobodies for the target protein allows the
direct attainment of structural information on thewild-type TM287/288
expressed in cellular membranes without the need to purify or label
the investigated membrane protein.
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Single domain antibodies (named nanobodies) are extremelyversatile tools that in recent years gained great scientific in-
terest in different fields from basic science to drug discovery (1–4).
Their classical generation relies on immunizations of animals,
which is difficult for delicate membrane proteins, and generally
impedes selections in the presence of ligands typically needed to
populate defined conformational states. To overcome these limi-
tations, an in vitro selection platform based on synthetic single
domain antibodies, named sybodies, was recently developed (5, 6).
Despite their low molecular weight (∼15 kDa), nanobodies
and sybodies exhibit high affinity and specificity for the desired
target, which make them suitable both for in vitro and in-cell
studies as shown by recent publications in the fields of protein
crystallization (for one example see ref. 7) and protein locali-
zation in cells with microscopy techniques (two recent examples
can be found in refs. 8 and 9).
We introduce here the use of spin-labeled nanobodies for
electron paramagnetic resonance (EPR) spectroscopy. The clas-
sical approach in site-directed spin-labeling EPR relies on the
attachment of different types of spin labels, mostly via cysteine
chemistry, to the protein of interest (for a recent review see ref.
10). The most prominent information that can be obtained via
EPR to gain structural insights into biological systems is the dis-
tance distribution between pairs of spin labels. When two (or
more) spin probes are present in the system (11–14), interspin
mean distances and their distributions can be extracted at cryo-
genic temperature with high precision. The four-pulse double
electron–electron resonance technique (DEER, also known as
PELDOR) is the most established method to measure distances
from 1.5 up to 15 nm between couples of spin labels in biomole-
cules (15). Through distance measurements under different exper-
imental conditions, conformational changes and equilibria between
different protein states can be monitored in vitro and used to
propose functional models of biologically relevant molecular
machines (a few recent examples can be found in refs. 16–19).
EPR studies in a truly native environment still represent a
challenge, due to the intrinsic difficulty of labeling and/or inserting
proteins in the cell. Toward this goal, several approaches have
been tested, such as protein expression with unnatural amino acids
carrying a stable paramagnetic center (20), insertion of a recom-
binantly produced spin-labeled protein inside the cell (21, 22) via
hypotonic swelling or electroporation, or spin labeling of bacterial
proteins directly in the outer membrane of bacteria (23, 24).
Here, we propose an approach based on protein-specific
nanobodies, spin labeled with gadolinium (Gd) probes, which
bind with high affinity to their target in physiological environ-
ments. The advantage of using spin-labeled nanobodies is that
they can be easily inserted into cells with conventional techniques
(e.g., osmotic shock, hypotonic swelling, or electroporation) and
can provide structural information on their target via internano-
body distances detection. This method is particularly helpful in the
case of membrane proteins, that cannot be delivered inside of the
cell with the above-mentioned techniques.
Two scenarios are possible: if one spin-labeled nanobody is
bound to each target protein, the interspin distance between
nanobodies report on protein interaction networks, or alternatively,
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if two nanobodies bind to the same target, they can report on
conformational changes of the protein. In this work, we used a
dodecane tetraacetic acid (DOTA)-chelated gadolinium ion (Fig.
1), a contrast agent already employed in magnetic resonance im-
aging (25, 26), which is biocompatible and nontoxic due to its
negligible rate of metal release. This property is also a prerequisite
for a good spin label for protein science, because losing the metal
ion from the chelator decreases the maximal achievable modulation
depth in DEER and consequently the signal-to-noise ratio. In
contrast to nitroxide-based spin labels, gadolinium labels do not
suffer from chemical reduction in a cellular medium and were
proven to be valuable for in-cell EPR studies (see for example refs.
21, 27, and 28). In addition to that, Gd-based labels are spectro-
scopically orthogonal to nitroxides (i.e., they are characterized by
different spectra, relaxation properties, and transition moments).
Therefore, if both labels are present in the same sample, it is pos-
sible to independently obtain the gadolinium–gadolinium,
nitroxide–nitroxide, and nitroxide–gadolinium distances via three
different DEER channels, increasing the information content
achievable in one sample (see for example refs. 29 and 30).
To provide a proof of principle, we focus here on different
state- and nonstate-specific nanobodies binding to a wild-type ABC
transporter and show that they can report its conformational dy-
namics in vitro and in cellular membranes.
ABC transporters are complex molecular machines that cou-
ple the energy derived from binding and hydrolysis of ATP with
large conformational changes that alternate the transporter’s con-
formation between an inward- and an outward-facing state (IF and
OF, respectively), in order to translocate substrates across the
membrane. In this study, we investigate TM287/288, a bacterial
heterodimeric exporter extensively studied in our groups (17, 31–
34) for which we recently solved three outward-facing crystal
structures with the help of sy- and nanobodies (17). The sybody
(called Sb_TM#35) was found to be state specific toward the
outward-facing conformation of TM287/288 (KD <100 nM). One
of the two nanobodies binding to the nucleotide-binding domains
(Nb_TM#1) was found to have a single-digit nanomolar KD for
the outward-facing state of TM287/288, and no complex could be
formed with the apo-state of the transporter up to submicromolar
concentrations, as shown by surface plasmon resonance (SPR); in
contrast, the second nanobody (Nb_TM#2) showed no binding
preference for the IF or OF state of the transporter, therefore it is
nonstate specific. The availability of the nanobody-transporter
structures was highly useful to determine the positions of the
engineered cysteines required to spin label the sy- and nanobodies
for DEER studies.
The careful design of the spin-labeled nanobodies allowed us
to monitor the switch of the wild-type transporters from the OF
to the IF state under turnover conditions and to exploit the
specificity of the selected nanobodies toward TM287/288 to
perform DEER measurements in intact inner membranes of
Escherichia coli.
Results
The three single domain antibodies (17) and the selected spin-
labeling sites chosen for this study are shown in Fig. 1. Their
binding epitopes in the IF and OF states are presented. Sb_TM#35
inhibits ATPase activity of the transporter and binds only in the
presence of ATP to the extracellular region, thereby shifting the
IF/OF equilibrium of the transporter toward the OF state. In
contrast, Nb_TM#2 binds sideways to NBD288 regardless of the
presence or the absence of ATP. Although Nb_TM#2 does not
appear to be conformation specific, it slightly inhibits the ATPase
activity as well (17).
Nb_TM#1 decreases the ATPase activity and binds specifi-
cally to the transporter in the OF state to an epitope that is
shared between the two nucleotide-binding domains (NBDs) (17).
For this study, Sb_TM#35 was labeled with gadolinium-
maleimide-DOTA at position 71, Nb_TM#1 at position 44,
and Nb_TM#2 at position 63 (Fig. 1). Labeling efficiencies
based on mass spectrometry analysis were found to be 95%,
100%, and 65%, respectively (SI Appendix, Fig. S1).
ATPase activity and SPR experiments revealed that labeling of
the nanobodies only marginally affected their properties (SI
Appendix, Table S1). However, we noted that the maximal re-
sponse units in the SPR measurements were consistently reduced
for the gadolinium-maleimide-DOTA–labeled binders.
Using the available structures, the labeling sites in Nb_TM#1
and #2 were carefully chosen on the basis of rotamer calcula-
tions using the Matlab-based package MMM (35), in order to
obtain a distance distribution centered around 5 nm between the
two spin labels when both nanobodies are bound to the trans-
porter (Fig. 1). Due to the state specificity of Nb_TM#1, the
detection of this distance between the Nb_TM#1 and Nb_TM#2
will provide the fingerprint of the OF state.
Previously we showed that the unlabeled sybody shifts the
conformational equilibrium of TM287/288 toward the OF state
(17); therefore, we investigated here the effect on the equilibrium
upon binding of the unlabeled and Gd-labeled sy/nanobodies. To
this end, we monitored nitroxide–nitroxide distances between
pairs of nitroxide spin labels [(1-oxyl-2,2,5,5-tetramethylpyrroline-
3-methyl)methanethiosulfonate (MTSL)] engineered at the NBDs
and in the intracellular region of the transporter (Fig. 1). In par-
ticular, we focused on the pair 460TM287/363TM288, which has been
investigated in a previous study (31), to monitor the effect of
Sb_TM#35 and Nb_TM#1 (Fig. 2). In the case of Nb_TM#2,
the presence of a spin label at position 363TM288 prevented
Fig. 1. Binding epitopes and labeling sites of the three sybody/nanobodies
under investigation. (A) TM287/288 in the apo-state, adopting an IF con-
formation (PDB file: 4Q4H) with the nonstate-specific nanobody Nb_TM#2
(in orange) docked to the structure. The backbone atoms of the eight amino
acids labeled for control experiments with MTSL in TM287 (gray) and TM288
(cyan) are highlighted. (B) Crystal structure of the OF conformation of the
protein obtained from the superposition of the PDB files 6QUZ, 6QV1, and
6QV2, to highlight the binding sites of the three nanobodies in the presence
of ATP. The clouds in the nanobodies’ structures represent the rotamers of
the Gd-maleimide-DOTA spin labels attached to the engineered cysteines
obtained with the Matlab-based package MMM (48). The Inset shows the
structure of the label bound to a cysteine.
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nanobody binding due to a steric clash. Therefore, we used the
pair 131TM288/248TM288 instead, which is located at the intra-
cellular portion of the transmembrane domains (Fig. 2 in the
presence of Nb_TM#2 and SI Appendix, Fig. S2 with Sb_TM#35).
None of the nanobodies affected the protein conformation in
the apo-state (SI Appendix, Fig. S3). The effects of nanobody
binding on the IF/OF conformational equilibrium in the presence
of ATP-EDTA (ethylenediaminetetraacetic acid) are shown in
Fig. 2 and SI Appendix, Fig. S2. The chelator EDTA was used to
sequester the magnesium ions present in the sample, which are
necessary to catalyze ATP hydrolysis.
We observed an almost complete shift of the equilibrium to-
ward the OF state in the presence of Sb_TM#35 and Nb_TM#1.
Notably, labeling with Gd-maleimide-DOTA was found to slightly
reduce the equilibrium shift. For the nonstate-specific Nb_TM#2,
only a negligible equilibrium shift was observed.
While Nb_TM#1 and Nb_TM#2 did not form homo- or
heterodimers in aqueous solutions, the sybody exhibited a long
Gd–Gd distance centered at 6 nm, indicative of dimer formation
(SI Appendix, Fig. S5), which seems to be an intrinsic charac-
teristic of Sb_TM#35, already shown with the MTSL-labeled
variant (17). In order to exclude the dimerization as a possible
cause for the reduced shift in equilibrium, we added a three-fold
excess of the Gd-labeled sybody and found no difference in the
DEER traces (SI Appendix, Fig. S5).
As mentioned in the introduction, one of the advantages of
using gadolinium as a spin probe in the nanobody relies on its
spectroscopic orthogonality with MTSL. Therefore, by placing a
pair of nitroxides at different positions within the transporter, one
can simultaneously investigate the effects of nanobody binding on
the transporter’s conformation via nitroxide–nitroxide distances,
the nanobody binding to the transporter via Gd–nitroxide dis-
tances, and the nanobody–nanobody interactions via Gd–Gd
distances.
We show the advantages of the nitroxide–Gd DEER channel
by spin labeling TM287/288 at position 54TM287 with MTSL and
the sybody at position 71 with Gd-maleimide-DOTA. We per-
formed DEER experiments on the sample in the absence and in
the presence of ATP (Fig. 3). In the apo-state, we did not observe
dipolar coupling between the gadolinium and nitroxide spin labels,
confirming that the state specificity observed by SPR at sub-
micromolar concentrations at room temperature is maintained for
Sb_TM#35 in frozen conditions up to the concentration used in
the DEER experiment (25 μM). Upon addition of ATP-EDTA,
the appearance of a dipolar modulation with a distance distribu-
tion centered at 4.3 nm provided a clear indication of the binding
of the sybody at the extracellular wing (Fig. 3 A and B). The ex-
perimental distance was found to be slightly longer than the pre-
dicted distance based on the OF structure (Fig. 3C).
When another position on the transporter, 271TM287, was
labeled with MTSL, we detected a 3.5-nm distance between sybody
and transporter, in good agreement with the MMM predictions.
Two distinct peaks at 3.5 and 4.3 nm could also be distinguished
when the Gd-labeled sybody was bound to the doubly labeled
transporter (54TM287-271TM287) in the ATP-bound state, which
shows the sensitivity of DEER to obtain precise structural infor-
mation from multimodal distance distributions. Moreover, we
attempted to monitor the long 7- to 9-nm distance predicted be-
tween the Gd spin label and two nitroxide labels (231TM287-
304TM287) across the transmembrane region, opposite from the
binding site of the sybody. The limited length of the DEER time
trace is related to large uncertainties in the obtained distance
distribution (Fig. 3C and SI Appendix, Fig. S6); therefore, a
maximal mean distance of 7 nm is the upper experimental limit for
the spin type and concentration used.
We then further proceeded with the study of the unlabeled
wild-type transporter using the two Gd-labeled nanobodies
Nb_TM#1 and Nb_TM#2 as reporters of the protein’s confor-
mational states. Based on the previous knowledge on the con-
formational specificity of Nb_TM#1, a dipolar frequency should
only be observed when both nanobodies are bound to the outward-
facing transporter. The modulation depth of the dipolar frequency
is directly proportional to the percentage of the OF state present in
the conformational ensemble. In the absence of nucleotides, the
OF state is not populated, whereas the addition of ATP is suffi-
cient to partially populate it. The maximal shift toward the OF
state is observed with ATP-vanadate (ATP-Vi-Mg), which mimics
Fig. 2. Effects of sybody/nanobody binding to the IF/OF equilibrium. (Upper) Primary DEER data for the nitroxide–nitroxide (NO–NO) distances of the
nucleotide-binding domain pair 460TM287-363TM288 in the ATP-bound state in the absence (−) and presence (+) of Sb_TM#35 (A) and Nb_TM#1 (B). (C) Primary
DEER data for the nitroxide–nitroxide distances of the intracellular pair 131TM288-248TM288 in the ATP-bound state in the absence and presence of Nb_TM#2.
(Lower) Corresponding distance distributions obtained with Tikhonov regularization together with MMM simulations for the OF and the IF conformations
(green and gray shaded areas, respectively). For each pair, the NO–NO distances were measured without the sybody or nanobody (−Sb/−Nb), with the un-
labeled sybody or nanobody (+Sb/+Nb), and with the Gd-labeled sybody or nanobody (+Gd-Sb/+Gd-Nb). The corresponding form factors and the error es-
timation of the distance distributions are shown in SI Appendix, Figs. S3 and S4. The IF/OF equilibrium shift of the unlabeled sybody was shown previously (17).





























the posthydrolytic transition state intermediate, while in the ADP-
bound state the equilibrium is shifted back toward the IF state.
As expected, we retrieved this information quantitatively from
the analysis of the modulation depth of the Gd–Gd traces
(nanobody–nanobody distances) for the wild-type transporter
trapped in different states (Fig. 4). By ranking the OF percentage
according to increasing modulation depths, we observed that
apo < ADP < ATP-EDTA = ATP-Vi-Mg. This rank order is in
line with the data from nitroxide–nitroxide distances in the spin-
labeled transporter (31), with the exception that we observed the
same percentage of OF states in the ATP-EDTA and the ATP-
vanadate state (Fig. 4). This is due to the shift toward the OF
state induced by the state-specific nanobody Nb_TM#1 in the
presence of ATP-EDTA (Fig. 2).
The 5 nm mean Gd–Gd distance obtained from DEER data
analysis (Fig. 4) is in good agreement with the predictions, in-
dicating that both nanobodies bind simultaneously to their dif-
ferent binding epitopes. With our Q-band setup (see Materials
and Methods), the maximal modulation depth detected between
two Gd-DOTA–labeled sites with 100% labeling efficiency is
∼3.5 to 4.0%, in line with previously published data obtained
with a slightly larger excitation bandwidth and a similar setup
(36). We observed a smaller maximal modulation depth
of ∼2.5% (Fig. 4), which is due to the 65% labeling efficiency of
Nb_TM#2 (SI Appendix, Fig. S1) and the 20% molar excess of
each nanobody with respect to the transporter concentration
(Materials and Methods). To ensure the reliability of the infor-
mation extracted from the contrast in the modulation depths in
the apo- and ATP samples, we performed a statistical analysis
with several repetitions on the ATP-EDTA sample in detergent.
Using the same fitting parameters for the background, we
obtained a mean modulation depth of 2.5% with a SD of 0.1%
(SI Appendix, Fig. S7).
The internanobody experimental distance distribution is broad
(2-nm full width at half maximum) and is in line with the 1.5-nm
width predicted by the MMM simulation. Therefore, we reason-
ably ascribe this characteristic to the intrinsic flexibility of the Gd-
DOTA linker and not to the disorder in the nanobody–transporter
interface. Notably, different linkers which are under development
in the field might alleviate this problem (37). To verify the reli-
ability of the distance distribution for the fraction of distances
>5 nm, we measured a longer trace (4.5 μs) on the ATP-EDTA
sample and performed error analysis (SI Appendix, Fig. S8). The
distance distribution was found to be very similar to that obtained
Fig. 3. Sybody binding to the transporter via Gd–nitroxide distances. (A)
Sybody-bound crystal structure of TM287/288 in the OF state (PDB file:
6QV0). The spin-labeled residues (MTSL on the transporter, in gray, and Gd-
maleimide-DOTA, in blue, on the sybody) are depicted with the rotamers
predicted by MMM2018. (B) Primary Gd–nitroxide DEER data. (C) Distance
distributions obtained with Tikhonov regularization for the different
transporter/sybody systems and simulated distance distributions (shaded
areas). For the 231TM287-304TM287-71Sb complex, the predicted distance dis-
tribution for 231TM287-71Sb is displayed in purple, while the 304TM287-71Sb
distance is colored in pink. The extracted distance distribution for this pair
was obtained by Gaussian model fit (dashed line) to stabilize the output
distances with respect to a Tikhonov model-free fit. The corresponding form
factors and error estimations are shown in SI Appendix, Fig. S6.
Fig. 4. Fingerprint nanobody–nanobody distances obtained in the presence
and absence of nucleotides. Background-corrected DEER data (Upper) and
corresponding distance distributions normalized by modulation depth (Lower)
characteristic of the Gd–Gd distances between Nb_TM#1 and Nb_TM#2 in the
different conformational states of the transporter. The values of the mod-
ulation depth are given on the right of the corresponding trace. The error in
the modulation depth, calculated as SD of six repetition experiments is 0.1%
(SI Appendix, Fig. S7). An increase in the modulation depth relates to an
increase of the population of the OF state. (Lower) The shaded area repre-
sents the MMM simulation. The corresponding primary data are shown in SI
Appendix, Fig. S9.
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with the 3-μs trace. The main focus of this part of the study is the
reliable extraction of the modulation depth parameter; therefore,
to optimize the signal-to-noise and to minimize the accumulation
time, 3-μs traces were recorded.
All DEER measurements presented in Fig. 4 were carried out
at a transporter concentration of 5 μM. This comparatively low
spin concentration was chosen to minimize errors in the de-
termination of the modulation depth due to background fitting
uncertainties. In contrast to our previous findings on the state
specificity toward the OF state of Nb_TM#1, we noticed a de-
tectable and reproducible residual dipolar coupling in the apo-
state (modulation [mod.] depth 0.5 ± 0.1%), indicating that
Nb_TM#1 weakly binds to the apo-transporter.
To further investigate the origin of this feature, nitroxide–
nitroxide DEER data on the intracellular pair 131TM288/248TM288
labeled with MTSL in the presence of Nb_TM#1 and Nb_TM#2
labeled with Gd-DOTA were carried out, proving that, in the
absence of nucleotides, the OF state is not populated (SI Ap-
pendix, Fig. S10). As the state-specific nanobody occupies an
epitope that is shared between the two NBDs, which do not
largely dissociate in the absence of nucleotides (33, 34), we
reasoned that a small fraction of Nb_TM#1 might bind with
weak affinity to the transporter in the apo-state as well. Unspecific
binding of Nb_TM#1 to the apo-transporter was not previously
assessed with SPR (17), where the maximal concentration was one
order of magnitude lower than the one used in DEER. To resolve
this discrepancy, SPR measurements were performed at micro-
molar concentrations of Nb_TM#1 using immobilized wild-type
apo-TM287/288. In line with the DEER data, Nb_TM#1 was
found to weakly bind to the apo-state (KD > 10 μM, SI Appendix,
Fig. S11). SPR measurement artifacts were excluded by the ab-
sence of binding signal when probing against the control protein
MsbA. We further corroborated these findings via detection of
residual Gd–NO dipolar coupling between the Gd–nanobody
and the nitroxide–transporter in the apo-state (SI Appendix, Fig.
S12). Hence, despite the two orders of magnitude difference in
the affinities toward the OF and IF conformation of the wild-
type transporter, Nb_TM#1 can be considered fully state spe-
cific for the OF state only if added in a 1:1 stoichiometric ratio to
transporters below single-digit micromolar concentrations.
In summary, with spin-labeled nanobodies we can quantita-
tively measure the different fractions of the OF state in an en-
semble of wild-type transporters in response to ATP binding, and
the contrast between the modulation depths in the apo- and ATP-
EDTA state (0.5 ± 0.1 vs. 2.5 ± 0.1%, respectively) is satisfactory
at single-digit micromolar concentrations of the transporter–
nanobody complex.
Next, we monitored the transporter during its working cycle in
the presence of ATP-Mg. When the sample was quickly shock
frozen in liquid nitrogen within 40 s after ATP-Mg addition, the
Gd–Gd modulation depth was smaller (1.8 ± 0.1%) compared to
the ATP-vanadate state (2.5 ± 0.1%), indicating that there is a
smaller fraction of OF states in the ensemble (Fig. 5). The sample
was then thawed and incubated for 20 min at 37 °C before being
shock frozen and measured again. Based on the residual ATPase
activity of the wild-type transporter in detergent (SI Appendix, Fig.
S1D), this incubation is sufficient to hydrolyze nearly all ATP
molecules in the sample. Indeed, we observed a significant de-
crease in the modulation depth, which reached a value similar to
the one obtained in the apo-state (Fig. 5). Therefore, as expected,
the incubation resulted in an almost complete switch of the
transporter to the inward-facing conformation, which cannot be
probed by the Gd-labeled nanobodies. In the bottom panel of Fig.
5, a bar chart representing the modulation depth (related to the
fraction of OF state) in the different conditions is reported.
To corroborate our interpretation, we compared the trend in
theOF fractions obtained byGd–Gdmodulation depths with the IF/OF
ratio extracted from the nitroxide–nitroxide distance distributions
using an orthogonally spin-labeled nanobodies/transporter com-
plex. To this end, the transporter was labeled with MTSL at the
intracellular pair 131TM288/248TM288 and incubated with Nb_TM#1
and Nb_TM#2 labeled with Gd-maleimide-DOTA. We com-
pared the modulation depth of the gadolinium–gadolinium DEER
traces (related to the amount of OF state) and the distance dis-
tributions obtained from the nitroxide–nitroxide DEER traces
(indicative of the relative amount of IF and OF in the sample)
before and after incubation with ATP-Mg (SI Appendix, Fig.
S13). Indeed, we found a high degree of correlation between the
decrease of the modulation depth in the Gd–Gd DEER traces
during hydrolysis and the decrease in the OF/IF intensity ratio in
the distance distributions obtained from the nitroxide–nitroxide
DEER channel.
Finally, to explore the specificity of the nanobodies toward
their target in a cellular context, we overexpressed TM287/288 in
E. coli cells, and prepared inside-out vesicles (ISOVs) as de-
scribed in Materials and Methods. This type of cellular prepara-
tion allows for monitoring how different substrates, inhibitors,
and other ligands affect membrane proteins, which expose their
cytoplasmic domains toward the exterior of the vesicles. Impor-
tantly, the two nanobodies Nb_TM#1 and #2 are expected to
bind to the accessible NBDs of the transporter in ISOVs. Hence,
the population of outward-facing TM287/288 can in principle be
monitored in the cellular membrane environment without the
need to purify and reconstitute the transporter.
Based on the yield of TM287/288 from cells harvested after 4 h
of overexpression, the mean transporter concentration in the
ISOVs preparation was estimated to be around 5 μM, similar to
the bulk concentration used in the detergent samples. In the pres-
ence of ATP-EDTA and upon addition of the two nanobodies at a
concentration of 6 μMeach, we obtained a clear dipolar modulation
Fig. 5. IF/OF interconversion under turnover conditions of wild-type trans-
porter. (Upper) Background-corrected DEER data during the Mg-dependent
hydrolysis of ATP. The traces obtained in the apo- and ATP-vanadate states
from Fig. 4 are shown as lower and upper limits of the modulation depths.
(Lower) Bar chart showing the values of the modulation depths in the four
different samples, given as a mean value. The error calculated as SD of six
repetition experiments is 0.1% (SI Appendix, Fig. S7). The primary data are
shown in SI Appendix, Fig. S9.





























in the primary DEER traces (Fig. 6A, dark green trace) charac-
terized by a modulation depth of about 1%, indicating that the
transporter concentration is in the estimated range.
The smaller modulation depth found in ISOVs compared to
the one in detergent (2.5 ± 0.01%, see Fig. 4) accounts for the
fact that the transporter concentration cannot be easily estimated
and that the preparation of the ISOVs has variable efficiencies in
the range of 70 to 90%, meaning that not all transporters have
their NBDs facing the outside of the vesicles. This introduces
an additional complication in the estimation of the transporters
interacting with the nanobodies. The internanobody distance is
very similar to that obtained using detergent-solubilized wild-type
transporters (Fig. 6C, green dotted). Hence, the nanobodies rec-
ognize the same epitopes in the cellular membrane, and outward-
facing TM287/288 exhibits the same relative distance between the
nucleotide-binding domains in membranes and in detergent. As a
control, we prepared ISOVs containing overexpressed MsbA (an
ABC exporter with considerable sequence homology to TM287/
288 in the nucleotide-binding domains, where the nanobodies’
epitopes are located, and similar expression levels in E. coli) and
no dipolar modulation could be retrieved under the same exper-
imental conditions (Fig. 6A, black trace). In summary, these ex-
periments demonstrate the selectivity of the nanobodies toward
their target in cellular membranes.
Unexpectedly, we detected a very poor contrast in the mod-
ulation depths when the ISOVs were measured in the absence of
ATP, and the DEER signal detected in the apo-state persisted
also after prolonged incubation with Mg2+, proving that there is
no residual ATP in the sample (SI Appendix, Fig. S14A). This
indicates that the weak affinity of Nb_TM#1 to the apo-state
(KD > 10 μM), together with high local concentrations of the
overexpressed transporters in the membranes, is detrimental for
the selective recognition of the OF state from the analysis of the
DEER traces. However, we found that incubating the ISOVs
with an excess of nanobodies (10 μM) and washing them by ul-
tracentrifugation to remove the nanobodies added in excess as
well as those weakly binding to the transporter, we could retrieve
a modulation depth of about 2% in the ATP state (comparable
to the detergent sample) and a satisfactory contrast between the
apo- and the ATP states (SI Appendix, Fig. S14B).
To verify if the high local concentrations of transporters is the
reason for the poor contrast in modulation depths observed in
the ISOVs, we prepared a second batch of cells with a lower
overexpression level (induction for 1 instead of 4 h), which showed
an improved apo–ATP contrast (SI Appendix, Fig. S14A). The
DEER traces detected on these ISOVs incubated with excess of
nanobodies (15 μM) and subjected to a washing step, show an
apo–ATP contrast and a modulation depth in the ATP state,
which are consistent with those obtained in detergent (Fig. 6B and
SI Appendix, Fig. S14B). In agreement with the better perfor-
mance in terms of modulation depth contrast, we found that re-
ducing the overexpression level also reduces the steepness of the
background of the DEER traces (SI Appendix, Fig. S14C) due to
lower local concentration of the transporters in the membrane.
In conclusion, the experiments with ISOVs provide clear evi-
dence that the two nanobodies show a distinct contrast in modu-
lation depths in the absence and presence of ATP-EDTA, thereby
selectively recognizing the OF state of TM287/288 in cellular
membranes.
Discussion
Here we show a proof-of-principle study on the use of spin-labeled
nanobodies as valuable tools for EPR structural investigations of
proteins in vitro and in cellular membranes. In particular, we
discuss their applicability on a specific class of membrane proteins,
namely ABC transporters, which are investigated in great detail by
EPR techniques (16, 17, 31, 38–42). Notably, the main novelty of
this approach is that with the spin-labeled nanobodies, we can
explore unlabeled wild-type membrane proteins in cellular con-
text, as the spin label is placed on the nanobody. The technique
requires one or more spin-labeled nanobodies with nanomolar or
higher affinity toward the protein of interest, which can be obtained
by immunization techniques or selected in vitro.
Fig. 6. Recognition of protein target and conformational states via
nanobody-mediated DEER measurements in cellular membranes. (A) Primary
DEER data between Nb_TM#1 and Nb_TM#2 in inside-out vesicles obtained
from cells in which TM287/288 is overexpressed for 4 h (dark green), com-
pared to a control sample containing overexpressed MsbA (black). Both sam-
ples were incubated with ATP-EDTA. (B) Contrast between the apo- and ATP-
EDTA state in ISOVs containing TM287/288 (1-h overexpression), incubated
with an excess of nanobodies (15 μM), and washed with the corresponding
buffers. For comparison, the ATP-EDTA trace in detergent is shown as a dotted
line. (C) Internanobody distance distributions obtained in the presence of ATP-
EDTA in detergent-purified protein (dashed line, teal) and inside-out vesicles
before and after washing (solid line, dark and light green).
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Spin-labeled nanobodies as conformational reporters for EPR
share the closest analogies to fluorescent nanobodies targeting
endogenous proteins in cells (9), which were recently introduced
for advanced light microscopy and can also possibly be used for
Förster resonance energy transfer (FRET) studies. For technical
reasons, the minimal spin concentration detectable by EPR is in
the low micromolar range (1 to 5 μM), while for fluorescence
studies, nanomolar to single molecule detection is possible.
However, in contrast to FRET, with DEER we can obtain with
high precision the distance distributions between the same labels
for mean distances in a 1.5- to 16-nm range (the high distance
limit was obtained with protein and solvent deuteration, ref. 43).
Realistically, for gadolinium-labeled nanobodies, the maximum
detectable distance in cellular membranes may be restricted to 6 to
8 nm at single-digit micromolar spin concentration in the absence
of extensive protein and solvent deuteration (Fig. 6). Furthermore,
spin-labeled nanobodies offer additional advantages. In EPR we
are not restricted to the use of two different spin labels to re-
trieve interspin distances, thereby the labeling schemes are
simpler. In analogy to different colors of fluorescent proteins,
different types of spin labels, such as gadolinium, trityl, copper,
and nitroxide, could be covalently attached to nanobodies as
well. Notably, for in-cell studies the spin labels need to be fully
biocompatible (44, 45).
An important advantage of nanobodies directly targeting the
investigated protein is that there are no flexible linkers between
the protein and the label, which is usually the case for genetic
fusion of fluorescent proteins, that may result in an uncoupled
motion of the “label” with respect to the protein. In our study,
we decorated TM287/288 with nanobodies that are rigidly bound
to the protein, as demonstrated by the similar width of the ex-
perimental distance distribution and the one simulated on a rigid
protein structure with both nanobodies bound to their epitopes
(Figs. 1 and 4). Therefore, the conformational freedom of the
nanobody is minimal and does not add up to the internal dis-
order of the gadolinium spin label for EPR studies. Due to their
characteristics, these molecules are perfect candidates to inves-
tigate conformational dynamics and protein–protein interactions
on wild-type proteins down to spin concentrations of a few
micromolar.
However, as attaching a spin label at a specific position in a
protein can interfere with its conformational equilibrium and/or
its function (for example the ATPase activity in a spin-labeled
ABC transporter depends on the site chosen for the labeling),
nanobodies can also cause similar effects. Here we show that the
nanobodies Nb_TM#1 and Nb_TM#2 indeed affect the IF/OF
equilibrium and decrease the ATPase activity, but still allow the
transporter to hydrolyze ATP, as shown by the turnover experi-
ments. Interestingly, we also found that, while Sb_TM#35 retains
its state specificity also at double digit micromolar concentrations,
Nb_TM#1 partially loses this characteristic already at single-digit
micromolar concentrations due to its weak affinity toward the apo-
state. Clearly, the state specificity is reflected in the contrast (in
this case in terms of modulation depth) between the fraction of
bound nanobodies to the transporter in different states, and it is a
concentration-dependent parameter. Based on the value of KD
obtained by SPR (>10 μM), we estimated that, with 5 μM trans-
porter and stoichiometric ratios of nanobodies (conditions used
for DEER in detergent samples), around 20% of the nanobody
is bound in the apo-state (in line with the mod. depth of 0.5 vs.
2.5% in the apo- and ATP-EDTA samples). Notably, in native
membranes, we found that high local concentrations of the over-
expressed target membrane proteins further reduce the contrast.
Therefore, lower overexpression levels are preferable to perform
DEER in cellular membranes.
For all these reasons, each nanobody must be carefully char-
acterized before being chosen for the desired use. While the use
of state-specific nanobodies can be advantageous as they can
provide fingerprint distances related to a particular conformational
state of a protein, our results suggest that nonstate-specific nano-
bodies may be more suitable as pure conformational reporters, as
shown for Nb_TM#2, because they minimally affect the protein’s
activity, and do not suffer from concentration-dependent state-
specificity issues. Having two such nanobodies binding to differ-
ent epitopes would allow for monitoring of different conforma-
tions directly on the wild-type target protein via distinct distances
(i.e., distinct dipolar frequencies), which will produce a more
reliable and richer analysis.
In our study, we made extensive use of orthogonal labeling
strategies: 1) we performed different experiments on the same
sample (e.g., effect of nanobody binding on the protein’s equilib-
rium, nanobody binding to the protein, nanobody self-dimerization);
and 2) we validated the findings on the wild-type protein by
comparison with the nitroxide-labeled variant. Therefore, we show
that it is possible to establish in vitro the optimal nanobodies for
in-cell EPR studies.
Additionally, we demonstrate that spin-labeled nanobodies can
selectively bind to their target protein in the inner membranes
of E. coli, and thereby permitting the investigation of confor-
mational changes under near-native conditions in membrane
vesicles.
Our work sets the stage for using biocompatible Gd-labeled
nanobodies as a tool in EPR spectroscopy for the structural and
biochemical analysis of wild-type proteins embedded in cellular
membranes. As discussed in the introduction, electroporation
methods to introduce small proteins into cells have already proven
to be successful.
Our results show that standard high-power Q-band arbitrary
waveform generator (AWG) spectrometers already have the
potential to investigate Gd-labeled proteins at concentrations
down to the single-digit micromolar range in cellular membranes.
Exploiting in the future the advantages of ultrawideband excita-
tion schemes, more sophisticated DEER sequences and higher
frequencies will further increase the signal-to-noise ratio of the Gd
traces, thereby fostering applications of this method. In-cell DEER
experiments will face new challenges and will require the opti-
mization of tools to verify the correct subcellular localization of
the nanobodies (via superresolution microscopy) as well as to
achieve stoichiometric nanobody/target ratios to maximize the
measured signals.
Materials and Methods
The two nanobodies and the sybody were identified as part of a previous
study (17). Single cysteines were introduced at positions S71 (Sb_TM#35),
Q44 (Nb_TM#1), and S63 (Nb_TM#2) using site-directed mutagenesis.
The proteins were produced fused tomaltose-binding protein (MBP) in the
periplasm of E. coli, purified under reducing conditions in the presence of
DTT (dithiothreitol), cleaved off from MBP by 3C protease, again purified by
reverse Immobilized-Metal Affinity Chromatography and separated using
size-exclusion chromatography as described in detail in a previous study (17).
Purified Sb_TM#35_S71C and Nb_TM#1_Q44C were stored in 20 mM Tris·HCl
pH 7.5, 150 mM NaCl with 2 mM DTT at −80 °C until labeling with Gd-
maleimide-DOTA was performed.
The DEER measurements were performed at 50 K (nitroxide–nitroxide) or
10 K (nitroxide–Gd, Gd–Gd) on a Bruker ELEXSYS E580Q AWG dedicated-
pulse Q-band spectrometer equipped with a 150 W traveling-wave tube
amplifier. A 4-pulse DEER sequence with Gaussian (46), nonselective ob-
server and pump pulses of 32-ns length (corresponding to 13.6 ns full width
at half maximum) with 100-MHz frequency separation was used for NO–NO
and Gd–Gd measurements; in the case of Gd–NO measurements, pump
pulses of 24-ns length (10.2 ns FWHM) were used in combination with 32-ns
observer pulses, with 280-MHz separation. For the Gd–Gd measurements, we
found that a small zero-time artifact due to pulse overlap could be removed by
using a 10-dB attenuation in the general attenuator. DEER experiments were
performed using the dead-time free four-pulse DEER sequence with 16-step
phase cycling. Experimental details regarding the pump and observer positions
in the different experiments are given in SI Appendix, Fig. S15, while SI Ap-
pendix, Fig. S16 shows, as an example, two echo decays for the wild-type





























transporter in the presence of Nb_TM#1 and Nb_TM#2, both labeled with
gadolinium-maleimide-DOTA, in the presence of ATP in detergent and in ISOVs.
The evaluation of the DEER data was performed using DeerAnalysis2019 (47).
Interspin distance simulations were performed with MMM2018 (48).
The final concentration of the detergent-solubilized spin-labeled trans-
porter was 25 μM, and was 5 μM for the wild-type unlabeled transporter. A
total of 40 μL of sample was loaded in quartz tubes with 3-mm outer di-
ameter. The ATP-EDTA sample contained 2.5 mM ATP and 2.5 mM EDTA to
completely inhibit ATP hydrolysis; samples were incubated at 25 °C and snap
frozen in liquid nitrogen. For vanadate trapping, samples were incubated
with 5 mM sodium orthovanadate, 2.5 mM ATP, and 2.5 mMMgCl2 for 3 min
at 50 °C and snap frozen in liquid nitrogen. For DEER measurements under
turnover conditions, 2.5 mM ATP and 2.5 mM MgCl2 were added to the
sample and snap frozen in liquid nitrogen. Each nanobody was added to the
TM287/288 in 1.2:1 stoichiometric ratio, if not elsewhere specified. The ISOVs
were incubated with both nanobodies in the absence or presence of 2.5 mM
ATP-EDTA and washed via ultracentrifugation at 120,000 × g.
Additional information can be found in SI Appendix.
Data Availability. All data are available upon request from the corresponding
authors.
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